GEHC GE HealthCare Technologies Inc. NASDAQ · United States

GE HealthCare Technologies (GEHC) news

GE HealthCare Technologies Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker GEHC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest GE HealthCare Technologies news

We have not published a story on GE HealthCare Technologies yet. When there is news, it will appear here.

GE HealthCare Technologies annual financials

Line	FY2025	FY2024
Revenue	$20.62 billion	$19.67 billion
Research and development	$1.26 billion	$1.31 billion
Net income (loss)	$2.08 billion	$1.99 billion
Cash and equivalents	$4.49 billion	$2.87 billion

Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $2.83 billion.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about GE HealthCare Technologies

What is the ticker symbol of GE HealthCare Technologies?

GE HealthCare Technologies Inc. trades under the ticker GEHC on NASDAQ.

Where is GE HealthCare Technologies listed?

GE HealthCare Technologies Inc. is listed on NASDAQ.

Which country or territory is GE HealthCare Technologies listed under?

Our directory records GE HealthCare Technologies Inc. under United States.

Does aibio.space cover GE HealthCare Technologies?

aibio.space lists GE HealthCare Technologies Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was GE HealthCare Technologies's revenue last year?

$20.62 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is GE HealthCare Technologies profitable?

GE HealthCare Technologies Inc. reported net income of $2.08 billion for the fiscal year ended Dec 31, 2025, per its annual report to the SEC.

How much does GE HealthCare Technologies spend on research and development?

$1.26 billion in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does GE HealthCare Technologies have?

$2.83 billion in cash at Sep 30, 2026, per its 10-Q.

Investor discussion: GE HealthCare Technologies

Members talk about GE HealthCare Technologies (GEHC). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:GEHC on TradingView.

Listing details

Company: GE HealthCare Technologies Inc.
Ticker: GEHC
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction